(Q38140769)

29 August 2017

title

DNA methylation biomarkers as diagnostic and prognostic tools in colorectal cancer (English)

1 reference

29 August 2017

0 references

0 references

1 reference

2

Efthimia K Basdra

1 reference

29 August 2017

author name string

Melina-Theoni Gyparaki

series ordinal

1

1 reference

29 August 2017

Athanasios G Papavassiliou

series ordinal

3

1 reference

29 August 2017

language of work or name

1 reference

21 September 2013

1 reference

Journal of Molecular Medicine

29 August 2017

published in

1 reference

29 August 2017

volume

91

1 reference

29 August 2017

issue

11

1 reference

29 August 2017

page(s)

1249-1256

1 reference

29 August 2017

cites work

Cancer statistics, 2013

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1088-Z

Progress in colorectal cancer survival in Europe from the late 1980s to the early 21st century: the EUROCARE study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1088-Z

Biomarkers in cancer staging, prognosis and treatment selection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1088-Z

CpG island methylator phenotype in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1088-Z

Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1088-Z

Epigenetic regulation of microRNA expression in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1088-Z

Hsa-miR-9 methylation status is associated with cancer development and metastatic recurrence in patients with clear cell renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1088-Z

The CpG island methylator phenotype and chromosomal instability are inversely correlated in sporadic colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1088-Z

Update on the serrated pathway to colorectal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1088-Z

DNA methylation predicts recurrence from resected stage III proximal colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1088-Z

Molecular features of colorectal hyperplastic polyps and sessile serrated adenoma/polyps from Korea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1088-Z

IGFBP7 is a p53-responsive gene specifically silenced in colorectal cancer with CpG island methylator phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1088-Z

Role of the serrated pathway in colorectal cancer pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1088-Z

TFAP2E-DKK4 and chemoresistance in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1088-Z

Epigenetic alteration of PRKCDBP in colorectal cancers and its implication in tumor cell resistance to TNFα-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1088-Z

Microsatellite instability in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1088-Z

The role of the CpG island methylator phenotype in colorectal cancer prognosis depends on microsatellite instability screening status

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1088-Z

Systematic review of microsatellite instability and colorectal cancer prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1088-Z

MicroRNAs as Novel Biomarkers in Colorectal Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1088-Z

Integrated analysis of chromosomal, microsatellite and epigenetic instability in colorectal cancer identifies specific associations between promoter methylation of pivotal tumour suppressor and DNA repair genes and specific chromosomal alterations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1088-Z

Septin 9 methylated DNA is a sensitive and specific blood test for colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1088-Z

Dysplasia-carcinoma transition specific transcripts in colonic biopsy samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1088-Z

Fecal DNA testing for Colorectal Cancer Screening: the ColoSure™ test

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1088-Z

Genome-wide identification and validation of a novel methylation biomarker, SDC2, for blood-based detection of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1088-Z

Detection and Clinical Significance of DLC1 Gene Methylation in Serum DNA from Colorectal Cancer Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1088-Z

N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1088-Z

Methylation of TFPI2 in stool DNA: a potential novel biomarker for the detection of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1088-Z

Detection of TFPI2 methylation in the serum of colorectal cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1088-Z

Tissue factor pathway inhibitor 2 (TFPI2) is frequently silenced by aberrant promoter hypermethylation in gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1088-Z

GATA4 and GATA5 are potential tumor suppressors and biomarkers in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1088-Z

Hypermethylated SFRP2 gene in fecal DNA is a high potential biomarker for colorectal cancer noninvasive screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1088-Z

Identification of an epigenetic biomarker panel with high sensitivity and specificity for colorectal cancer and adenomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1088-Z

The stool DNA test is more accurate than the plasma septin 9 test in detecting colorectal neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1088-Z

DNA methylation biomarkers for noninvasive diagnosis of colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1088-Z

Aberrant methylation of APC, MGMT, RASSF2A, and Wif-1 genes in plasma as a biomarker for early detection of colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1088-Z

Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1088-Z

MicroRNAs as Biomarkers in Colorectal Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1088-Z

Epigenetic silencing of the intronic microRNA hsa-miR-342 and its host gene EVL in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1088-Z

SP1 mediates the link between methylation of the tumour suppressor miR-149 and outcome in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1088-Z

CD133 as a biomarker for putative cancer stem cells in solid tumours: limitations, problems and challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1088-Z

PHLDA1 expression marks the putative epithelial stem cells and contributes to intestinal tumorigenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1088-Z

MLH1 promoter methylation frequency in colorectal cancer patients and related clinicopathological and molecular features

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1088-Z

Evaluation of markers for CpG island methylator phenotype (CIMP) in colorectal cancer by a large population-based sample

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1088-Z

Promoter methylation of Wnt5a is associated with microsatellite instability and BRAF V600E mutation in two large populations of colorectal cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1088-Z

Aberrant methylation of the p16 gene is frequently detected in advanced colorectal cancer.

21 January 2018

1 reference

12 December 2020

Methylation of TFPI2 gene is frequently detected in advanced well-differentiated colorectal cancer.

1 reference

12 December 2020

DNA methylation and cancer

1 reference

12 December 2020

CpG island methylation, response to combination chemotherapy, and patient survival in advanced microsatellite stable colorectal carcinoma

1 reference

12 December 2020

Downregulation of DLC-1 gene by promoter methylation during primary colorectal cancer progression

1 reference

12 December 2020

Analysis of APC and IGFBP7 promoter gene methylation in Swedish and Vietnamese colorectal cancer patients

1 reference

12 December 2020

Detection of methylated SEPT9 in plasma is a reliable screening method for both left- and right-sided colon cancers

1 reference

12 December 2020

RUNX3 promoter methylation in colorectal cancer: its relationship with microsatellite instability and its suitability as a novel serum tumor marker

1 reference

12 December 2020

CpG island methylation in colorectal cancer: past, present and future

1 reference

12 December 2020

Methylation of NEUROG1 in serum is a sensitive marker for the detection of early colorectal cancer

1 reference

12 December 2020

Colorectal cancer: molecular features and clinical opportunities

1 reference

12 December 2020

10.1007/S00109-013-1088-Z

Identifiers

DOI

1 reference

Dimensions Publication ID

29 August 2017

1042221170

0 references

1 reference